Calyxt Inc (CLXT.OQ)
CLXT.OQ on NASDAQ Stock Exchange Global Market
12.42USD
19 Oct 2018
12.42USD
19 Oct 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$12.42
$12.42
Open
$12.83
$12.83
Day's High
$12.96
$12.96
Day's Low
$12.38
$12.38
Volume
9,674
9,674
Avg. Vol
25,351
25,351
52-wk High
$26.66
$26.66
52-wk Low
$12.38
$12.38
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.30 | December | 23 Oct 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 3 | 3 |
| (2) OUTPERFORM | 1 | 1 | 1 | 0 |
| (3) HOLD | 2 | 2 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.83 | 1.83 | 1.60 | 1.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 5 | 2.52 | 4.60 | 0.78 | 27.85 |
| Quarter Ending Mar-19 | 3 | 3.05 | 3.94 | 1.80 | -- |
| Year Ending Dec-18 | 5 | 3.03 | 5.40 | 1.03 | 54.20 |
| Year Ending Dec-19 | 5 | 18.95 | 29.50 | 12.70 | 206.10 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 6 | -0.30 | -0.25 | -0.36 | -0.49 |
| Quarter Ending Mar-19 | 3 | -0.27 | -0.20 | -0.32 | -- |
| Year Ending Dec-18 | 6 | -1.02 | -0.93 | -1.10 | -1.08 |
| Year Ending Dec-19 | 6 | -1.14 | -0.92 | -1.31 | -1.03 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-18 | 0.12 | 0.20 | 0.08 | 67.95 |
| Quarter Ending Mar-18 | 0.14 | 0.01 | 0.13 | 92.35 |
| Quarter Ending Dec-17 | 0.05 | 0.19 | 0.13 | 262.57 |
| Quarter Ending Sep-17 | 0.11 | 0.04 | 0.07 | 61.17 |
| Quarter Ending Jun-17 | 0.08 | 0.22 | 0.15 | 197.33 |
| Earnings (per share) | ||||
| Quarter Ending Jun-18 | -0.21 | -0.25 | 0.04 | -17.48 |
| Quarter Ending Mar-18 | -0.29 | -0.16 | 0.13 | -44.52 |
| Quarter Ending Dec-17 | -0.18 | -0.23 | 0.05 | -29.07 |
| Quarter Ending Sep-17 | -0.14 | -0.51 | 0.37 | -255.40 |
| Quarter Ending Jun-17 | -0.32 | -0.17 | 0.15 | -47.16 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 2.52 | 2.52 | 2.52 | 4.07 | 27.85 |
| Quarter Ending Mar-19 | 3.05 | 3.05 | 2.60 | 1.80 | -- |
| Year Ending Dec-18 | 3.03 | 3.03 | 3.03 | 5.00 | 54.20 |
| Year Ending Dec-19 | 18.95 | 18.96 | 18.96 | 24.04 | 206.10 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | -0.30 | -0.30 | -0.30 | -0.32 | -0.49 |
| Quarter Ending Mar-19 | -0.27 | -0.27 | -0.24 | -0.23 | -- |
| Year Ending Dec-18 | -1.02 | -1.02 | -1.02 | -1.06 | -1.08 |
| Year Ending Dec-19 | -1.14 | -1.14 | -1.14 | -1.05 | -1.03 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Mar-19 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 1 | 0 | 1 |
| Year Ending Dec-19 | 0 | 1 | 0 | 1 |
| Earnings | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Mar-19 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates- RPT-INSIGHT-Gene-editing startups ignite the next 'Frankenfood' fight
- INSIGHT-Gene-editing startups ignite the next 'Frankenfood' fight
- INSIGHT-Gene-editing startups ignite the next 'Frankenfood' fight
- Battle lines drawn as EU court weighs fate of gene-edited crops
- Battle lines drawn as EU court weighs fate of gene-edited crops